368 related articles for article (PubMed ID: 30680578)
1. Economic Impact of Diabetes in Africa.
Mapa-Tassou C; Katte JC; Mba Maadjhou C; Mbanya JC
Curr Diab Rep; 2019 Jan; 19(2):5. PubMed ID: 30680578
[TBL] [Abstract][Full Text] [Related]
2. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review.
Hall V; Thomsen RW; Henriksen O; Lohse N
BMC Public Health; 2011 Jul; 11():564. PubMed ID: 21756350
[TBL] [Abstract][Full Text] [Related]
3. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
4. Costs of diabetes and its complications in Poland.
Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
[TBL] [Abstract][Full Text] [Related]
5. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
[TBL] [Abstract][Full Text] [Related]
6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
7. Cost of diabetes mellitus in Africa: a systematic review of existing literature.
Mutyambizi C; Pavlova M; Chola L; Hongoro C; Groot W
Global Health; 2018 Jan; 14(1):3. PubMed ID: 29338746
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia.
Ganasegeran K; Hor CP; Jamil MFA; Loh HC; Noor JM; Hamid NA; Suppiah PD; Abdul Manaf MR; Ch'ng ASH; Looi I
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32784771
[TBL] [Abstract][Full Text] [Related]
9. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.
Hex N; Bartlett C; Wright D; Taylor M; Varley D
Diabet Med; 2012 Jul; 29(7):855-62. PubMed ID: 22537247
[TBL] [Abstract][Full Text] [Related]
10. Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
Javanbakht M; Baradaran HR; Mashayekhi A; Haghdoost AA; Khamseh ME; Kharazmi E; Sadeghi A
PLoS One; 2011; 6(10):e26864. PubMed ID: 22066013
[TBL] [Abstract][Full Text] [Related]
11. [Direct and indirect diabetes costs in the world].
Logminiene Z; Norkus A; Valius L
Medicina (Kaunas); 2004; 40(1):16-26. PubMed ID: 14764977
[TBL] [Abstract][Full Text] [Related]
12. The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study.
Erzse A; Stacey N; Chola L; Tugendhaft A; Freeman M; Hofman K
Glob Health Action; 2019; 12(1):1636611. PubMed ID: 31282315
[No Abstract] [Full Text] [Related]
13. The impact of diabetes mellitus on healthcare costs in Italy.
Giorda CB; Manicardi V; Diago Cabezudo J
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
[TBL] [Abstract][Full Text] [Related]
14. Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005--a register-based approach.
Bolin K; Gip C; Mörk AC; Lindgren B
Diabet Med; 2009 Sep; 26(9):928-34. PubMed ID: 19719715
[TBL] [Abstract][Full Text] [Related]
15. The current total economic burden of diabetes mellitus in the Netherlands.
Peters ML; Huisman EL; Schoonen M; Wolffenbuttel BHR
Neth J Med; 2017 Sep; 75(7):281-297. PubMed ID: 28956787
[TBL] [Abstract][Full Text] [Related]
16. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
[TBL] [Abstract][Full Text] [Related]
17. A total cost perspective of type 1 and 2 diabetes mellitus in two South African medical schemes servicing the public healthcare sector.
Opperman AM; De Klerk M
S Afr Med J; 2021 Jun; 111(7):635-641. PubMed ID: 34382546
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing the economic costs associated with type 1 and type 2 diabetes.
Dall TM; Mann SE; Zhang Y; Quick WW; Seifert RF; Martin J; Huang EA; Zhang S
Popul Health Manag; 2009 Apr; 12(2):103-10. PubMed ID: 19361253
[TBL] [Abstract][Full Text] [Related]
19. Predictions Burden of Diabetes and Economics Cost: Contributing Risk Factors of Changing Disease Prevalence and its Pandemic Impact to Qatar.
Bener A; Al-Hamaq AO
Exp Clin Endocrinol Diabetes; 2016 Sep; 124(8):504-511. PubMed ID: 27023007
[No Abstract] [Full Text] [Related]
20. Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach.
Foos V; Wang K; McEwan P; Zhang Y; Xin P; Jiang X; Qu S; Xiong T; De Moor R; Ramos M; Lamotte M; Ji L
Value Health Reg Issues; 2019 May; 18():36-46. PubMed ID: 30419449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
